Viratech Announces Agreement for License of Technology Platform for Cancer Patients
30 5월 2013 - 10:00PM
Marketwired
Viratech Corp. (PINKSHEETS: VIRA), the first open source biotech
research social network platform, announced today the signing of an
agreement for a license issued from Chris Ryan and Kevin Buckman
for a patent-pending, provisional application titled "Method of
Lowering a Cancer Patient's Morbidity Rate by Increasing Quality of
Life of Patient by Leveraging Cause-Based Electronic Social Support
Networks."
This invention was created to lower morbidity in cancer patients
by creating an online, cause-based Social Support Network (SSN) for
the benefit of cancer patients based on the modular adaption,
construction and best practices implementation of the European
Organization for Research and Treatment of Cancer (EORTC), and
Quality of Life Questionnaire-C30 (QLQ-C30). There are other
benefits to cancer patients and this platform can be used for other
medical disorders, like diabetes, heart diseases, or even as a
business development platform. The invention is the driving force
behind Cancer.im, Viratech's social network resource site for
cancer patients, survivors, advocates and volunteers
(http://www.youtube.com/watch?v=dz1tHRb3wvU )
The Social Support Network is made up of miniature social
networks, called Micro Support Networks (MSN), which revolve around
a single user, or Beneficiary, who is facing a particular challenge
or obstacle related to cancer. This is also a way to help cancer
patients with needed solutions and sources of vital information
about their disease.
About Cancer.im
Viratech's subsidiary, Cancer.im, Inc., owns and operates
http://cancer.im, a social network resource site for cancer
patients, survivors, advocates and volunteers. Cancer.im harnesses
social collaboration utilities to develop what Viratech believes
will become the first experience-based search engine powered by
social collaboration. Cancer.im's mission is to empower every
cancer patient, regardless of their ability to pay, with the power
to research their disease and to find, organize, and manage their
own cancer support network.
This invention was based on the study at Fox Chase Medical
Center that is part of a National Comprehensive Cancer Network,
that was published as a double-blind, placebo-controlled study
titled "Quality of Life (QOL) Supersedes the Classic Predictors of
Survival in Locally Advanced Non Small Cell Lung Cancer
(NSCLC).
This important study demonstrates that it is possible to
directly lower the incidence of morbidity in a cancer patient,
regardless of treatment. Using this study and added information
gathered over years of interviews of many patients in the US and
other countries, this was integrated into technologies to help
cancer patients, their friends and families, and even health care
providers decrease mortality in cancer patients and increase
quality of life and provide many other benefits to cancer
patients.
This invention relates to a method of creating an SSN for the
benefit of the Cancer Community (CC) allowing the Beneficiary the
ability of recruiting resources and support via an online
collaborative based community.
About Viratech Corp.
Based in Stockton, California, Viratech Corp. has created an
open source biotech research and development platform. Viratech has
created a unique platform leveraging the utility of social
collaboration, which will allow cancer research the opportunity for
the first time to become open sourced. This is accomplished by
allowing our development partners the ability to protect, promote
and produce their research in unified online collaboration hubs
known as micro social networks. Viratech's open source platform has
integrated several intellectual property tools which, by leveraging
our social collaboration network, can give our development partners
a new intellectual property mechanism, which will help in
addressing the protection of Intellectual Property, promotion
through collaboration in our protected open source platform, and
commercial development of the products achieved through
collaborative research.
Using this platform, Viratech members can protect their
intellectual property, then use Viratech's micro social network as
a utility to promote and crowdfund the research and development to
produce the new technology.
Add to Digg Bookmark with del.icio.us Add to Newsvine
Contact: Dr. Kevin Buckman Viratech, Corp.
http://viratech.org Email Contact: Email Contact 209-477-3030
Viratech (PK) (USOTC:VIRA)
과거 데이터 주식 차트
부터 5월(5) 2024 으로 6월(6) 2024
Viratech (PK) (USOTC:VIRA)
과거 데이터 주식 차트
부터 6월(6) 2023 으로 6월(6) 2024